Results 131 to 140 of about 22,475 (211)

Study on anaesthetic agent propofol and sevoflurane as maintenance agent along with anti-emetic drug ondansetron in reducing post operative nausea and vomiting in high-risk patients. [PDF]

BMC Anesthesiol
Sunil L, Acharya GR.
europepmc   +1 more source

Ondansetron derivatives as potential PTP1B inhibitors for treating type 2 diabetes mellitus: <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> analysis. [PDF]

Front Pharmacol
Naeem F, Jiang W, Babar MM, Hussain SH, Ashraf Z, Sun J, Zafar S, Liu Q.   +7 more
europepmc   +1 more source

Comparing ondansetron versus phenylephrine in reduce the incidence of hypotension after spinal anesthesia in cesarean section. [PDF]

J Educ Health Promot
Majd MN, Shamsi A, Ali Alallo IH, Parnian M.   +3 more
europepmc   +1 more source

Oral food challenges in FPIES: A narrative review and proposals for emergency and home-based management of acute FPIES reaction. [PDF]

Pediatr Allergy Immunol
Jubin V, Dumond P, Benoist G, Amat F, Corvol H, Couderc-Kohen L, Deschildre A, Doc A, Divaret-Chauveau A, El Abd K, Linglart A, Metz-Favre C, Hoppe A, Levieux K, Morisset M, Valla F, Blanc S, Lemoine A, French Working Group Comprising the SFA (French Allergy Society), and the GFRUP (French‐speaking Pediatric Resuscitation and Emergency Group) and the Sp2A (French Society of Pediatric Pneumology and Allergology) of the SFP (French Pediatric Society).   +19 more
europepmc   +1 more source

Route-specific adverse effects of ondansetron: an overlooked concern in Asian clinical practice. [PDF]

Ann Med Surg (Lond)
Ur Rehman MU, Nisa NU, Hotak R.
europepmc   +1 more source

Prophylaxis of opioid-induced nausea in helicopter emergency medical service: a prospective quasi-experimental study. [PDF]

Scand J Trauma Resusc Emerg Med
Knapp J, Strohm R, Huber M, Albrecht R, Pietsch U.   +4 more
europepmc   +1 more source

Pharmacologic and Adjunct Therapies for Pediatric Gastroenteritis. [PDF]

J Pediatr Pharmacol Ther
Murugaiah C.
europepmc   +1 more source

Major Adverse Cardiac Events with Ondansetron: The Role of Observational Evidence to Inform Actionable Safer Prescribing in Cardio-Oncology. [PDF]

Clin Pharmacol Ther
Raschi E, Diemberger I, Poluzzi E, De Ponti F.   +3 more
europepmc   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT₃ Receptor Antagonists: 2026 Update. [PDF]

Clin Pharmacol Ther
Moore C, Bourque MS, Halman A, Agúndez JAG, Prows CA, Hikino K, Schwab M, Oxencis CJ, Chauhan D, Diekstra MHM, Long SE, Bell GC, Gaedigk A, Whirl-Carrillo M, Klein TE, Caudle KE, Conyers R.   +16 more
europepmc   +1 more source

Effect of ondansetron on QTc interval prolongation in healthy pediatric patients: a systematic review and meta-analysis. [PDF]

Rev Paul Pediatr
Carneiro IMC, Castelo Branco PES, Franco AHS, Oliveira AP, Aguiar AMA.   +4 more
europepmc   +1 more source